Tear Ferning Test for Dry Eye Diagnosis
- Conditions
- Dry Eye Syndromes
- Interventions
- Other: with/without dry eye syndrome
- Registration Number
- NCT06364943
- Lead Sponsor
- Chung Shan Medical University
- Brief Summary
Application of tear ferning test for clinical dry eye diagnosis
- Detailed Description
Comparing dry eye patients' tear ferning structure with non-dry eye patients' to develop a protocol for easy and costless diagnosis in ophthalmology.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
- Aged between 20 and 65 years
- For dry eye disease group:
- Schirmer's test results between 5 - 10 mm
- Tear Film Break Up Time less than 10 seconds
- Ocular Surface Disease Index of more than 25
- Those have diabetes, hypertension or other chronic diseases
- No evident ocular diseases such as cornea disease, cataracts, vitreous degeneration, glaucoma, and retinopathy.
- Belong to vulnerable groups(pregnancy woman, prisoner, ethical minorities, economic or educationally disadvantaged subjects, disabled individuals such as those at terminal stage of tumorigenesis, blindness, terminal ill individuals)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Non-Dry eye patients with/without dry eye syndrome Collect clinical information and tear samples from patients without dry eye syndrome.
- Primary Outcome Measures
Name Time Method Ocular surface health evaluate 3 minutes To assess the health status with Lissamine green stain
Tear film breakup time 20 seconds to assess tear quality
Schirmer's test 5 minutes to assess tear secretion volume
- Secondary Outcome Measures
Name Time Method Intraocular pressure 2 minutes to determine the effects of intervention on intraocular pressure
Ocular surface disease index 20 minutes A questionnaire to assess the health status on ocular surface
A final score is calculated which ranges from 0 to 100 with scores 0 to 12 representing normal, 13 to 22 representing mild dry eye disease, 23 to 32 representing moderate dry eye disease, and greater than 33 representing severe dry eye disease.
Trial Locations
- Locations (1)
Jen-Ai Hospital
🇨🇳Taichung,, Taiwan